Detalhe da pesquisa
1.
Safety of omalizumab in chronic urticaria during pregnancy: a real-life study.
Clin Exp Dermatol;
49(4): 344-347, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37956096
2.
Efficacy of Dupilumab in two patients with severe and recalcitrant atopic dermatitis previously treated with extracorporeal photopheresis.
Dermatol Ther;
33(3): e13284, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32092216
3.
A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab.
Dermatol Ther;
35(11): e15859, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36164841
4.
Long-term efficacy of a Vismodegib regime including a 1-week drug holiday every month in two patients with Gorlin Goltz syndrome.
Dermatol Ther;
35(3): e15293, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34964222
5.
Usefulness of in vivo reflectance confocal microscopy in Morbihan syndrome.
Skin Res Technol;
27(5): 974-976, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33455034
6.
Amenorrhea secondary to vismodegib: An adverse event to consider especially in female patients with Gorlin-Goltz syndrome.
Dermatol Ther;
33(4): e13527, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32383228
7.
Psoriasis and Fibromyalgia: A Systematic Review.
J Pers Med;
14(2)2024 Jan 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38392598
8.
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab.
Dermatitis;
2024 Apr 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38669092
9.
Exploring the Relationship Between Dermatology Life Quality Index, Eczema Area and Severity Index, and Sleep Numerical Rating Scale and Pruritus Numerical Rating Scale in Patients with Atopic Dermatitis Treated with Dupilumab.
Dermatitis;
34(5): 440-444, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36917539
10.
Teledermatology in 2020: past, present and future perspectives.
Ital J Dermatol Venerol;
156(2): 198-212, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33960751
11.
Dupilumab in Elderly Patients With Severe Atopic Dermatitis.
Dermatitis;
32(1S): S24-S27, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33332865
12.
Reading Patch Test Through Line-Field Confocal Optical Coherence Tomography Eyes.
Dermatitis;
35(2): 118-120, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37934230
13.
Line-field confocal optical coherence tomography (LC-OCT) in bullous striae distensae.
Ital J Dermatol Venerol;
159(1): 70-71, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37878269
14.
A proposed protocol for UVBnb phototherapy in a patient with severe AD and mild PSO treated with dupilumab.
Ital J Dermatol Venerol;
159(3): 358-360, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38197614
15.
Development of a sebo-psoriasis-like dermatosis: a newly paradoxical reaction due to ixekizumab described with line-field confocal optical coherence tomography.
Ital J Dermatol Venerol;
159(2): 197-198, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38127319
16.
Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations Despite Biological Therapy.
Dermatitis;
35(1): 107-109, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36976838
17.
Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab.
Dermatitis;
35(S1): S107-S108, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37594754
18.
Skin reaction following SARS-CoV-2 vaccine BNT162b2.
Ital J Dermatol Venerol;
158(4): 360-361, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37387638
19.
A case of transient paradoxical early morphea-like eruption after the first injection of dupilumab in a patient with chronic rhinosinusitis with nasal polyps.
Ital J Dermatol Venerol;
158(6): 495-497, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37721775
20.
Granulomatous Rosacea-Like Reaction During Dupilumab Treatment.
Dermatitis;
2023 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37432781